OPDP plans more research on presentation of 'targeted' MoAs
Regulatory NewsMichael Mezher
Advertising, Promotion and LabelingBiologics/ biosimilars/ vaccinesNorth AmericaPharmaceuticalsRegulatory NewsMichael MezherAdvertising, Promotion and LabelingBiologics/ biosimilars/ vaccinesNorth AmericaPharmaceuticals